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Abstract
Human papillomaviruses (HPV) are the causative agents of cervical cancers. The infectious HPV life cycle is closely linked to
the differentiation state of the host epithelia, with viral genome amplification, late gene expression and virion production
restricted to suprabasal cells. The E6 and E7 proteins provide an environment conducive to DNA synthesis upon
differentiation, but little is known concerning the mechanisms that regulate productive viral genome amplification. Using
keratinocytes that stably maintain HPV-31 episomes, and chemical inhibitors, we demonstrate that viral proteins activate
the ATM DNA damage response in differentiating cells, as indicated by phosphorylation of CHK2, BRCA1 and NBS1. This
activation is necessary for viral genome amplification, as well as for formation of viral replication foci. In contrast, inhibition
of ATM kinase activity in undifferentiated keratinocytes had no effect on the stable maintenance of viral genomes. Previous
studies have shown that HPVs induce low levels of caspase 3/7 activation upon differentiation and that this is important for
cleavage of the E1 replication protein and genome amplification. Our studies demonstrate that caspase cleavage is induced
upon differentiation of HPV positive cells through the action of the DNA damage protein kinase CHK2, which may be
activated as a result of E7 binding to the ATM kinase. These findings identify a major regulatory mechanism responsible for
productive HPV replication in differentiating cells. Our results have potential implications for the development of anti-viral
therapies to treat HPV infections.
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Introduction
Human papillomaviruses (HPV) are the etiological agents of
most anogenital cancers and their productive life cycle is
dependent upon epithelial differentiation [1,2]. HPVs infect cells
in the basal layer of stratified epithelia, but restrict the productive
phase of the life cycle to highly differentiated suprabasal cells [3].
Viral genome amplification, late gene expression and virion
production are induced in suprabasal cells that have re-entered S-
phase. In undifferentiated basal cells, viral genomes are main-
tained as episomes at approximately 100 copies per cell and
replicate in synchrony with cellular replication. In contrast, upon
differentiation HPV genomes are replicated to thousands of copies
per cell in a process referred to as amplification [4]. While normal
epithelial cells exit the cell cycle upon differentiation, HPV-
infected cells are able to over-ride normal checkpoint controls and
remain active in the cell cycle, allowing for the synthesis of cellular
proteins that are necessary for viral replication [5,6]. HPV
proteins activate low levels of caspases belonging to the intrinsic
pathway in differentiating cells, and this is necessary for viral
replication [7]. The mechanisms regulating productive replication
of HPVs upon differentiation, however, remain largely unknown.
The fidelity of cellular replication is controlled by signaling
pathways that block the propagation of damaged DNA [8,9].
Central to these repair pathways are the ATM (ataxia-telangiectasia
mutated), and ATR (ATM and Rad3-related) kinases, which belong
to a structurally related family of serine-threonine kinases that share
a PI-3 kinase-like domain, but only phosphorylate proteins [9].
ATM is a prime mediator of the cellular response to double strand
breaks [10], while ATR controls the response to UV damage, as
well as stalled DNA replication forks [11]. Both kinases act in part
by controlling cell cycle checkpoints at G1, S and G2. Several
viruses have been shown to interact with and/or affect components
of the ATM DNA damage pathway [12]. Herpes simplex virus
(HSV) induces an ATM-damage response as soonas pre-replication
centers are formed, and this activation is essential for productive
replication [13,14]. In contrast, adenovirus must mislocalize and
degrade DNA repair proteins to ensure viral replication [15]. Using
recombinant adenoviruses, high-level expression of HPV-16 E7 in
fibroblasts was shown to activate the ATM pathway [16], but it is
unclear whether these effects are physiologically significant, or if
they play any role in the viral life cycle.
ATM activates a number of downstream targets that are
involved in cell cycle control, apoptotic responses and DNA repair
[17]. These proteins can be divided into three pathways that lead
to activation of cell cycle checkpoints: a p53/mdm2 pathway, a
CHK2 branch, and a NBS1/BRCA1/SMC1 pathway. ATM
directly activates p53 by phosphorylation at serine 15, as well as by
phosphorylating Mdm2, the ubiquitin ligase that regulates p53
stability [18,19,20]. In the second pathway, ATM phosphorylates
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action of Cdc25 phosphatases [21,22]. Another branch of S-phase
checkpoint control involves ATM targeting of NBS1, a member of
the MRN double strand break repair complex [23]; BRCA1, the
breast cancer susceptibility protein [24]; and SMC1, a cohesin
binding protein [25,26]. An additional downstream activity of
ATM, as well as ATR, that is important for S-phase checkpoint
control is phosphorylation of the tail of a histone variant H2AX (c-
H2AX), which leads to recruitment of DNA damage regulatory
factors to distinct nuclear foci [27,28]. Phosphorylation of these, as
well as other targets allows for DNA damage to be assessed and for
repair to take place.
Given the importance of this pathway in controlling replication,
we investigated if ATM signaling was necessary for stable HPV
replication in undifferentiated cells, as well as productive
replication in differentiated cells. Our studies indicate that HPV
proteins induce an ATM response in both undifferentiated and
differentiated cells. Importantly, we found that ATM kinase
activity is necessary for viral genome amplification in differenti-
ating cells, but not for stable maintenance in undifferentiated cells.
These studies implicate HPV activation of DNA damage signaling
in controlling productive viral replication upon differentiation.
Results
HPV induces a DNA damage response
To determine if HPV induces a DNA damage response in
infected cells we first examined the expression level, as well as
activation status, of ATM by Western blot analysis (Figure 1C). For
these studies, we examined undifferentiated, as well as differentiated
human keratinocyte cell lines that maintain HPV-31 episomes at
approximately 50 copies per cell, and compared effects to a
matched set of normal human keratinocytes isolated from foreskin
circumcisions (HFKs). We have shown previously that calcium-
induced differentiation is sufficient to activate the productive phase
of the HPV life cycle by 48 hours [7]. Upon differentiation,
approximately 25% of HPV positive cells re-enter S phase and
undergo viral genome amplification, resulting in high levels of
episomal DNA [29] (Figure 1A). The induction of differentiation is
indicated by the expression of cellular proteins, such as keratin 10
(K10) and involucrin (Figure 1B). As shown in Figure 1C, the total
levels of ATM were similar between HPV-31 positive HFKs (HFK-
31) and matched normal HFKs in undifferentiated cultures, as well
as after 48 and 96 hours of differentiation in high calcium medium.
In response to double-strand breaks or changes in chromatin, ATM
is activated through the autophosphorylation of inactive, dimeric
ATMonserine1981,followedbydissociationintoactivemonomers
[30]. The phosphorylated form of ATM (Ser1981) was detected in
undifferentiated HPV-31 positive cells and maintained at a similar
level through 48 hours of differentiation, with a decrease occurring
at 96 hours (Figure 1C). In contrast, only a low level of pATM
Ser1981 was observed in normal HFKs. This pattern of ATM
phosphorylation was observed in multiple independently derived
polyclonal populations of HFK-31 cells, and matched normal
HFKs, as well as in CIN612 cells, which is a clonal cell line derived
from a HPV-31 positive biopsy (Bedell MA, 1991) (data not shown).
To determine if phosphorylation of ATM correlated with
activation of downstream targets, we examined the phosphorylation
status of three of its substrates: CHK2, NBS1 and BRCA1. CHK2 is
an important transducer of the ATM signaling pathway, and its
activation is initiated by ATM phosphorylation on threonine 68
(pCHK2) [21,22]. While pCHK2 was detected in both undifferen-
tiated and differentiated HPV-31 positive cells, only low levels were
detected in normal HFKs (Figure 1C), which correlates with the low
level of pATM detected in these cells. Activation of the ATM
pathwaycanalsoresultinthephosphorylation ofNBS1 and BRCA1,
both of which play important roles in DNA repair and the regulation
ofS and G2 checkpoints[24,31,32,33]. In HFK-31cells,BRCA1 was
phosphorylated at all states of differentiation (Figure 1C). While we
also observed pBRCA1 in undifferentiated normal HFKs, the levels
rapidly declined along with total BRCA1 upon differentiation.
Phosphorylation of BRCA1 in normal HFKs may be due to either
low level activation of ATM, or through the action of ATR, which
can also phosphorylate BRCA1 [24]. Importantly, phosphorylation
of NBS1 at Ser343 was induced only upon differentiation of HPV
positive cells, with low levels observed in undifferentiated cells
(Figure 1C). In contrast, little phosphorylation of NBS1 was observed
in either undifferentiated or differentiated normal HFKs (Figure 1C).
These results indicate that phosphorylation of NBS1 in HPV positive
cells is differentiation-specific, and correlates with the induction of
productive viral replication (Figure 1A). Interestingly, we observed
phosphorylation of the ATR substrate CHK1 on Ser317 in
undifferentiated HPV positive cells (Figure 1C), suggesting that
ATR is also active. However, the levels of phosphorylated CHK1, as
well as total CHK1, decreased by 48 hours post-differentiation.
Similar effects were observed in multiple independently derived
HFK-31 cell lines, as well as in CIN612 cells (data not shown).
Overall, these results indicate that HPV proteins induce a DNA
damage response that is maintained throughout the viral life cycle
and characterized by the activation of the ATM substrates CHK2,
NBS1 and BRCA1.
We next wanted to confirm that ATM activity was responsible
for CHK2 phosphorylation in HPV positive cells, as CHK2 can
also be phosphorylated and activated by the ATR kinase [22,34].
HFK-31 cells were treated with a small molecule inhibitor of
ATM, KU-55933, that inhibits kinase activity without affecting
the total levels of ATM [35] (Figure 1D). Treatment of HFK-31
cells with 5 or 10 uM of the ATM inhibitor resulted in significantly
reduced phosphorylation of CHK2, as well as ATM itself in
differentiated cells (Figure 1D). Treatment of HPV-31 cells with
this inhibitor also resulted in decreased phosphorylation of NBS1
and BRCA1 (data not shown), while phosphorylation of CHK1
Author Summary
Over 100 types of human papillomavirus (HPV) have been
identified, and approximately one-third of these infect
epithelial cells of the genital mucosa. A subset of these
HPV types are the causative agents of cervical and other
anogenital cancers. The infectious life cycle of HPV is
dependent on differentiation of the host epithelial cell,
with viral genome amplification and virion production
restricted to differentiated suprabasal cells. While normal
keratinocytes exit the cell cycle upon differentiation, HPV
positive suprabasal cells are able to re-enter S-phase to
mediate productive replication. The mechanisms regulat-
ing the activation of differentiation-dependent viral
replication are largely unknown. In this study, we
demonstrate that HPV induces an ATM-dependent DNA
damage response that is essential for viral genome
amplification in differentiating cells. In addition, we have
found that ATM signaling to its downstream target CHK2 is
critical for providing an environment that is conducive to
HPV productive replication. Our findings identify an
important regulatory mechanism by which HPV controls
replication during the productive phase of the life cycle
and may identify new targets for the development of
therapeutics to treat HPV-induced infections.
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PLoS Pathogens | www.plospathogens.org 2 October 2009 | Volume 5 | Issue 10 | e1000605Figure 1. HPV induces a cellular DNA damage response in infected cells. (A) DNA was harvested from undifferentiated (T0) HPV positive
cells, as well as after 48 and 96 hours of differentiation in high calcium. Southern blot analysis was performed to examine amplification of viral
genomes, represented by supercoiled (episomal) viral DNA. Standards of copies of HPV genomes per cell are indicated to the left of the gel.
(B) Lysates harvested from undifferentiated (T0) HPV-31 positive HFKs (HFK-31) and from normal HFKs, as well as cells differentiated in high calcium
medium for 48 and 96 hours, were analyzed by Western blot analysis for levels of the differentiation markers keratin 10 (K10) and involucrin.
(C) Lysates were harvested from undifferentiated HFK-31 and from normal HFKs, as well as cells differentiated in high calcium medium for 48 and
96 hours. Western blot analysis was performed using the indicated phospho-specific antibodies, as well as antibodies to detect total protein levels.
(D) HFK-31 cells were treated with DMSO as a vehicle control, or the indicated amounts of the ATM inhibitor KU-55933 for 48 and 96 in high calcium
medium. Lysates were harvested at the indicated times and analyzed by Western blot analysis for the activation of CHK2 (Thr68), CHK1 (Ser317), and
ATM (Ser1981), as well as antibodies to detect total protein levels. GAPDH served as a loading control. Ca=calcium.
doi:10.1371/journal.ppat.1000605.g001
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(Figure 1D). Treatment of undifferentiated HPV-31 positive cells
also resulted in inhibition of CHK2 phosphorylation without
affecting CHK1 phosphorylation (data not shown). These results
indicate that ATM activity is necessary for CHK2 phosphoryla-
tion in cells maintaining HPV genomes. In addition, our findings
indicate that the low level of CHK1 phosphorylation observed in
differentiating HPV positive cells is ATM-independent, and may
suggest a role for ATR in the non-productive phase of the life
cycle.
HPV does not induce degradation of MRN components
In response to DNA damage, ATM is recruited to distinct
nuclear foci by the MRN complex, which consists of NBS1,
MRE11 and RAD50 [36,37]. Recruitment to double strand
breaks allows for ATM-dependent phosphorylation of at least a
subset of downstream targets [10,38]. Adenoviruses abrogate the
ATM response by relocalizing and degrading components of the
MRN complex, which would normally promote the detrimental
concatemerization of viral genomes [15,39]. For HPV, the
amounts of MRE11 and RAD50 were found to be similar in
both undifferentiated and differentiated cells, as well as in HFKs,
while the levels of NBS1 were consistently higher in HPV-31 cells
compared to normal HFKs (Figure 2). In addition, components of
the MRN complex were localized to nuclear foci in HPV positive
cells (Figure S1). Overall, these results indicate that HPV does not
induce degradation of these repair proteins in order to facilitate
the viral life cycle, but instead maintains them at high levels
throughout differentiation.
HPV induces the accumulation of activated ATM, CHK2
and c-H2AX in nuclear foci
The detection of phosphorylated CHK2, NBS1 and BRCA1 in
HPV positive cells suggested that ATM may be localized to
nuclear foci, as is observed in cells undergoing a DNA damage
response [8]. To investigate this possibility, we examined the
localization of the phosphorylated form of ATM (Ser1981) in
HPV-31 positive cells by confocal fluorescence microscopy. As
shown in Figure 3A, pATM Ser1981 was found in distinct nuclear
foci in undifferentiated HPV-31 positive cells. pATM Ser1981
colocalized with c-H2AX, a modified histone associated with
double-stranded breaks [40], and these foci were retained upon
differentiation in a similar number of HPV-31 positive cells
(39.766.6%). In contrast, normal HFKs exhibited diffuse staining
of pATM, with only a few foci being detected in both
undifferentiated and differentiated cells (3.2%6.8 and 3.16.6%,
respectively). Inhibition of ATM activity by treatment with KU-
55933 abrogated formation of pATM-Ser1981 foci in HPV-31
positive cells (Figure 3A), and correlates with the decrease in
pATM levels observed in the presence of the inhibitor by Western
blot analysis (Figure 1D). Interestingly, the number of HPV-31
positive cells that exhibited c-H2AX foci upon 48 hours of
differentiation was reduced but not completely inhibited in the
presence of KU-55933 (40.7% to 10.8%), indicating that other
kinases, such as ATR [27], may contribute to this activity in HPV
positive cells. Similar results were observed in multiple HFK-31
lines, as well as CIN612 cells. These results suggest that HPV
induces the activation and accumulation of ATM and c-H2AX at
distinct sites in the nucleus.
We next examined the localization of phosphorylated CHK2
Thr68 in undifferentiated and differentiated cells. In undifferen-
tiated HPV-31 positive cells, a number of foci containing both
pCHK2 Thr68 and c-H2AX were detected, although every cell
did not stain positive for these foci (Figure 3B). Upon
differentiation in high calcium medium for 48 hours, the number
of foci containing both pCHK2 and c-H2AX was retained
(21.561.1%). In contrast, only smaller, less intense foci containing
pCHK2 and c-H2AX were detected in undifferentiated HFKs
(3.360.5%), and the number did not increase upon differentiation.
When HPV-31 positive cells were treated with the ATM inhibitor,
the formation of the pCHK2 foci was substantially diminished
(21.5% to 3.4%), further supporting a dependence on ATM
activity for CHK2 activation (Figure 3B). Calcium-induced
differentiation of HPV-31 positive cells and normal HFKs was
confirmed by staining for K10 (Figure 3C).
It was next important to confirm that pCHK2 Thr68
localization to nuclear foci was not specific to calcium-induced
differentiation. For these studies, HPV-31 positive keratinocytes,
as well as normal keratinocytes, were induced to differentiate by
growth in organotypic raft cultures, and immunohistochemistry
was performed on cross sections of the rafts. As shown in
Figure 3D, pCHK2 Thr68 was detected in the basal layer of HPV-
31 positive rafts, as well as in a large number of suprabasal cells
(67%), while only a few cells in the basal layer of normal HFK rafts
had a comparable signal (5%). These results correlate with the
CHK2 activation and nuclear localization observed upon calcium-
induced differentiation. In addition to CHK2, we also observed
similar staining patterns for pATM Ser1981, c-H2AX and
MRE11 in rafts of HPV-31 positive cells (Figure S2). Differenti-
ation of HFK-31 cells, as well as normal HFKs, using the raft
system was confirmed by staining for K10 (Figure S2). Overall,
these results indicate that an ATM DNA damage response is
activated in HPV-positive cells.
ATM and CHK2 kinase activity is required for viral
genome amplification in differentiating cells
We next investigated if activation of the ATM pathway is
necessary for stable replication of HPV genomes in undifferenti-
ated cells, or viral genome amplification in differentiated cells.
Figure 2. HPV does not affect the levels of the components of
the MRN complex. Lysates were harvested from undifferentiated
HFK-31 cells and normal HFKs, as well as from cells induced to
differentiate in high calcium for 48 and 96 hours. Western blot analysis
was performed using antibodies to NBS1, MRE11 and RAD50. Western
blots were stripped and re-probed with an antibody to GAPDH as a
loading control. Ca=calcium.
doi:10.1371/journal.ppat.1000605.g002
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PLoS Pathogens | www.plospathogens.org 4 October 2009 | Volume 5 | Issue 10 | e1000605Figure 3. HPV induces ATM activation and the accumulation of DNA repair proteins in nuclear foci. HFK-31 cells, as well as normal HFKs
were harvested, fixed and permeabilized at either time 0 (undifferentiated cells), or after 48 hours of differentiation in high calcium medium
containing DMSO, or 10 uM of the ATM inhibitor KU-55933. Samples were stained with (A) anti-pATM Ser1981 (red), anti-H2AX Ser139 (c-H2AX)
(green) antibodies; (B) anti-pCHK2 Thr68 (green), anti-c-H2AX (red) antibodies; or (C) an anti-K10 antibody as a marker of differentiation. Samples
were subsequently analyzed by confocal laser scanning microscopy using either a 606objective lens (panels A and B), or a 406objective lens (panel
C). Cellular DNA was counterstained with DAPI. (D) Sections from organotypic raft cultures generated from HFK-31 cells, or normal HFKs were stained
with an antibody to detect pCHK2-Thr68 (green). Cellular DNA was counterstained with DAPI. Images were visualized using confocal laser scanning
microscopy. Ca=calcium.
doi:10.1371/journal.ppat.1000605.g003
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undifferentiated HPV-positive cells, we first examined the effect of
inhibiting ATM kinase activity on episomal maintenance
(Figure 4A). HPV-31 positive cells were grown in monolayer
cultures and treated every two days with either DMSO as a vehicle
control, or 5 uM KU-55933 to inhibit ATM kinase activity. The
cells were passaged every five days and DNA was harvested at
every other passage. Southern blot analysis was then performed to
examine the status of the episomal viral DNA. As shown in
Figure 4A, cells treated with DMSO maintained a similar number
of episomes over time. We also found that cells treated with the
ATM inhibitor exhibited only modest fluctuations in copy number
as a function of extended passage. This experiment was performed
multiple times with similar results. Since viral episomes were not
rapidly lost upon passaging, these results indicate that ATM
activity is not essential for the stable maintenance of episomes in
undifferentiated cells.
To determine if ATM kinase activity is necessary for differen-
tiation-dependent viral genome amplification, HPV-31 positive
CIN612 cells were induced to differentiate in high calcium medium
in the presence of DMSO or KU-55933. DNA was harvested from
monolayer cells (0 hour), as well as 48 and 96 hours post-
differentiation. As shown in Figure 4B, Southern blot analysis for
HPV DNA demonstrated that cells treated with the ATM inhibitor
Figure 4. ATM activity is required for differentiation-dependent viral genome amplification, but not episomal maintenance. (A) DNA
was isolated at the indicated passages from undifferentiated HPV-31 positive CIN612 cells grown in the presence of DMSO, or the ATM inhibitor
KU-55933 and analyzed by Southern blot analysis for the presence of episomal (supercoiled) HPV DNA. (B, C) DNA was harvested from
undifferentiated (0 hour) CIN612 cells, as well as cells differentiated in high calcium (48 and 96 hr) in the presence of DMSO, (B) 5 or 10 uM KU-55933,
or (C) 5 uM CHK2 inhibitor (CHK2i) and analyzed for amplification of viral genomes by Southern blot analysis. (D) Lysates were harvested from
undifferentiated (0 hour) CIN612 cells, as well as from CIN612 cells induced to differentiate in high calcium in the presence or absence of 5 or 10 uM
KU-55933. Western blot analysis was performed using an antibody to keratin 10 (K10) and involucrin. (E) Lysates were harvested from undifferentiated
(T0) HPV-31 positive cells, as well as from cells induced to differentiate in high calcium for 48 and 96 hours in the presence or absence of DMSO.
Western blot analysis was performed using an antibody to K10. Blots were stripped and probed for GAPDH as a loading control. Ca=calcium.
doi:10.1371/journal.ppat.1000605.g004
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compared to cells treated with DMSO alone. This experiment
was repeated five times with identical results, demonstrating that
ATM activity is necessary for productive viral replication. Since
CHK2 is a major transducer of ATM signaling, we next wanted to
determine if CHK2 activity is necessary for viral replication in
differentiating cells. For this study, we used a specific inhibitor of
CHK2 activity that effectively blocks phosphorylation of down-
stream targets, without affecting its own phosphorylation (Figure
S4). Similarly to the ATM inhibitor, treatment of HPV-31 positive
cells with the CHK2 inhibitor resulted in greatly diminished viral
genome amplification upon differentiation (Figure 4C), indicating
that ATM signaling to CHK2 is essential for this activity. Similar
effects were also seen upon treatment of HFK-31 cell lines with the
ATM and CHK2 inhibitors (data not shown), as well as when viral
DNA was linearized by restriction digestion (Figure S3). Since
epithelial differentiation is necessary for activation of viral genome
amplification [41], we wanted to ensure that KU-55933 treatment
did not act indirectly by blocking epithelial differentiation. For this
analysis, we examined the expression levels of the differentiation-
specific markers K10 and involucrin by Western blot analysis
(Figure 4D). The subpopulation of differentiating cells that are
amplifying HPV DNA are in S or G2 phase and do not express
K10, while adjoining cells in G0/G1 synthesize high levels of K10
[29]. This is consistent with studies showing that upon keratinocyte
differentiation, K10 is expressed in post-mitotic cells that are still
metabolically active [42]. Treatment of HPV-31 positive cells with
concentrations of KU-55933 up to 10 uM minimally affected K10
and involucrin expression, indicating that ATM inhibition does not
alter differentiation (Figure 4D). To ensure that DMSO does not
affect epithelial differentiation, we compared K10 expression
between HPV-31 positive cells induced to differentiate in high
calcium in the presence or absence of DMSO, and found no
differences (Figure 4E).
Since we observed the formation of nuclear foci containing
pATM Ser1981 in HPV-31 positive cells and found that ATM
kinase activity is necessary for viral genome amplification, we
investigated whether ATM activity is required for the formation of
HPV replication foci in differentiating cells. For these studies,
tyramide-enhanced fluorescence in situ hybridization (FISH) was
used to detect viral genomes in cells that were treated with
DMSO, or 10 uM of the ATM inhibitor. In monolayer cells, only
single foci of viral genomes were detected in a small number of
cells (9.662.3%) (Figure 5), which is consistent with previous
observations [29]. In contrast, after differentiation for 48 hours in
high calcium medium, the number of cells containing viral
genome foci, as well as number and size of the foci, greatly
increased (4861.9%). Treatment with the ATM inhibitor
prevented the formation of multiple foci per cell, resulting in a
staining pattern similar to that of undifferentiated cells, providing
further evidence that ATM activity is necessary for viral
replication in differentiating cells.
HPV activates CHK2 to induce caspase cleavage upon
differentiation
We previously showed that HPVs induce low-levels of caspase 3/
7 activation upon differentiation and that this is important for
cleavage ofthe E1replicationproteinandgenomeamplification[7].
The studies described above indicate that HPV requires CHK2
activity for productive replication (Figure 4C). In addition to its
activity in DNA repair and cell cycle checkpoint function, CHK2
also plays a role in damage-induced apoptosis [16,43,44,45], and
thus could potentially contribute to the caspase activation observed
in differentiating HPV-31 positive cells. To investigate this
possibility, HPV-31 CIN612 cells were induced to differentiate in
high calcium in the presence of DMSO or 5 uM of the CHK2
inhibitor. Cells extracts were harvested as a function of time and
examined by Western blot analysis for cleavage of caspase-7. As
shown in Figure 6, inhibition of CHK2 significantly impaired
caspase-7 cleavage as compared to cells treated with DMSO alone,
without affecting total levels of caspase-7. Similar results were found
upon treatment of HFK-31 cells with the CHK2 inhibitor (data not
shown). This finding, coupled with the observation that CHK2 is
Figure 5. Formation ofreplication foci is impaired in the absence
of ATM activity. FISH analysis was performed using undifferentiated
(T0), as well as differentiated (48 hr high calcium) HPV-31 positive HFKs
using a HPV-31 nick translated probe (green). FISH analysis was also
performed on HPV positive cells grown in high calcium for 48 hr in the
presence of 10 uMKU-55933. Cellular DNA was counterstained withDAPI,
and images were visualized using confocal laser scanning microscopy.
Ca=calcium.
doi:10.1371/journal.ppat.1000605.g005
Figure 6. HPV-mediated caspase activation requires CHK2
kinase activity. Lysates were harvested from undifferentiated (0 hour)
HPV-31 positive CIN612 cells, as well as from HPV-31 cells induced to
differentiate in high calcium in the presence of DMSO or 5 uM of the
CHK2 inhibitor (CHK2i) for the indicated times. Western blot analysis
was performed using antibodies to detect the cleaved (active) form of
caspase-7, as well as an antibody to detect pro-caspase-7. GAPDH
served as a loading control. Ca=calcium.
doi:10.1371/journal.ppat.1000605.g006
HPV Amplification Requires ATM
PLoS Pathogens | www.plospathogens.org 7 October 2009 | Volume 5 | Issue 10 | e1000605required for productive replication, indicates that HPVs utilize
ATM signaling to promote caspase activation through CHK2,
allowing for enhanced viral replication in differentiating cells.
High-risk E7 induces CHK2 phosphorylation and interacts
with ATM
To determine which viral proteins could be responsible for
ATM activation, we first examined a possible role of E7 in this
process, since it has been shown to de-regulate cell cycle control
upon differentiation [46]. Our studies indicate that keratinocytes
stably expressing HPV-31 E7 from the pLXSN retroviral vector
exhibit phosphorylation of CHK2 on Thr68 in undifferentiated
and differentiated keratinocytes, with little activation observed in
cells expressing the pLXSN vector alone (Figure 7A). Since E7
mediates the majority of its functions through protein-protein
interactions [46], we next investigated if E7 interacts with ATM.
For these studies, we utilized the osteosarcoma cell line U2OS,
which contains both wild-type p53 and Rb. U2OS cells were
Figure 7. E7 induces CHK2 phosphorylation upon differentiation and interacts with the phosphorylated form of ATM. (A) Lysates
were harvested from HFKs transduced with the retroviral vector pLXSN alone, or pLXSN-HPV-31 E7 at 0 hr (undifferentiated cells), as well as after
differentiation in high calcium for 48 and 96 hours. Western blot analysis was performed using a phospho-specific antibody to pCHK2 Thr68, as well
as an antibody to total CHK2. GAPDH served as a loading control. Ca=calcium. (B) Lysates were prepared from U2OS cells transiently transfected with
vectors expressing HA, wild-type HA-31E7, HA-31E7 DLHCYE or HA-31E7 L67R. Immunoprecipitations were performed using an antibody to
endogenous ATM, followed by Western blot analysis using an antibody to HA. (C) Immunoprecipitations were performed on lysates harvested from
U2OS cells transfected with HA alone, HA-E7, HA-E7 DLHCYE or HA-E7 L67R using an antibody to HA followed by Western blot analysis to detect
precipitated pATM Ser1981. (D) Lysates were prepared from transfected U20S cells treated with DMSO or 10 uM KU-55933 for 12 hours.
Immunoprecipitatations were performed using an antibody to ATM, followed by Western blot analysis using an antibody to HA.
IP=Immunoprecipitation, IB=Immunoblot. No Ab=No antibody (control).
doi:10.1371/journal.ppat.1000605.g007
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HA-E7 lacking the LXCXE Rb binding motif (DLHCYE), or with
an HA-E7 HDAC binding mutant (L67R). Following transfection,
proteins associated with endogenous ATM were isolated by
immunoprecipitation using an antibody to ATM, followed by
Western blot analysis using an antibody to HA to detect
precipitated E7 proteins. As shown in Figure 7B, wild-type E7
and the HDAC binding mutant were both able to co-
immunoprecipitate with ATM, although the HDAC binding
mutant was less efficient in doing so. In contrast, the interaction
between E7 and ATM was abrogated in cells transfected with the
LXCXE Rb-binding mutant, which is also defective for productive
HPV replication [47]. Several proteins in addition to Rb have
been shown to interact with E7 at this site [46], and it is unclear
whether the binding of E7 to ATM is direct or is mediated through
another protein or complex of proteins. We also performed
immunoprecipitations using an antibody to the HA tag, followed
by Western blot analysis for pATM Ser1981, and found that E7 is
able to bind the phosphorylated form of ATM (Figure 7C). Again,
the HDAC binding mutant was still able to interact with pATM,
but to a lesser degree than wild-type E7. We consistently observed
that the L67R mutant was expressed at lower levels than wild-type
HA-E7, as well as the Rb-binding mutant, and likely accounts for
the decreased binding of this mutant to ATM. To determine if
ATM phosphorylation is necessary for E7 to interact with ATM,
U20S cells transfected with wild-type HA tagged E7 were treated
with 10 uM of the ATM inhibitor KU-55933, which inhibits the
phosphorylation of ATM (Figure 1D). Endogenous ATM was
precipitated, followed by Western blot analysis using an antibody
to HA to examine the presence of E7 in the precipitated
complexes. As shown in Figure 7D, E7 co-precipitated with
ATM in cells treated with DMSO alone, but not in cells treated
with the ATM inhibitor. Since total levels of ATM were not
affected by treatment with the ATM inhibitor (Figure 7D), these
results suggest that E7 interacts primarily with the phosphorylated
form of ATM. Overall, these results indicate that E7 activates
CHK2, possibly through its association with ATM, which may in
turn be important for the productive phase of the viral life cycle.
Discussion
In this study, we show that human papillomaviruses activate the
ATM DNA damage response and that this is necessary for
productive viral replication upon differentiation. These findings
identify a primary regulatory mechanism responsible for HPV
genome amplification. Our studies indicate that papillomaviruses
induce phosphorylation of ATM, as well as its substrates CHK2
and BRCA1, in undifferentiated cells, but this activation has
minimal effect on the long-term maintenance of HPV episomes. In
differentiating cells, the phosphorylation of NBS1, well as CHK2
and BRCA1, was observed and inhibition of the ATM pathway
completely blocked amplification of viral genomes. In addition, we
found CHK2 activity to be required for HPV-mediated caspase
activation, as well as viral genome amplification. It is possible that
activation of the ATM response in differentiating cells induces an
S or G2/M arrest that provides an environment conducive to
productive viral replication. HPV genomes replicate bi-direction-
ally via theta structures in basal cells, but may switch to replication
by a rolling circle mechanism during amplification [48]. This
switch in replication modes may also require activation of the
ATM pathway specifically in differentiating cells.
HSV-1 and SV40 have been shown to recruit members of the
ATM DNA damage pathway to specific sites of replication in the
nucleus [49,50,51]. In differentiating cells undergoing productive
replication of HPV genomes, we observed the formation of
nuclear foci containing pATM, pCHK2 and c-H2AX, as well as
the MRN components, MRE11 and RAD50. The addition of
ATM inhibitors prevented formation of these foci and blocked
viral genome amplification, further implicating these DNA repair
proteins as important regulators of HPV productive replication.
We did not observe a complete loss in the formation of c-H2AX
foci upon treatment with the ATM inhibitor, however this may be
due to the actions of other checkpoint kinases, such as ATR and
DNA-PK [27]. Consistent with this idea, we observed ATM-
independent phosphorylation of the ATR target CHK1 on Ser317
in undifferentiated cells, as well as in differentiated cells, although
at decreased levels.
Our studies further demonstrate that the addition of a specific
inhibitor to CHK2 blocks viral genome amplification. Upon
activation, CHK2 phosphorylates the Cdc25a and Cdc25c
phosphatases to initiate cell cycle arrest in G1/S or G2/M
through their degradation or cytoplasmic sequestration, respec-
tively [52]. Cdc25c is necessary for the activation of Cdc2/Cdk1,
as well as entry into mitosis, and its inactivation plays a central role
in inducing G2/M arrest [53]. Preliminary results indicate that
phosphorylation of Cdc25c on Ser216 increases in HPV positive
differentiating cells (Figure S4), as does inhibitory phosphorylation
of Cdc2/Cdk1 on Tyr15 (Moody and Laimins, unpublished data),
and this occurs in a CHK2-dependent manner. These results are
consistent with ATM-dependent activation of CHK2 leading to a
G2/M arrest and viral genome amplification. Recent studies
suggest that HPV infected cells undergoing productive replication
are arrested at G2/M rather than in S-phase and is consistent with
our findings [54].
The MRN complex appears to be important for HPV
amplification, as the phosphorylated forms of CHK2, NBS1 and
BRCA1 were detected in differentiated HPV positive cells. For
some viruses, the DNA damage response represents an obstacle
that must be overcome for efficient replication. For example, the
adenovirus E1b55K/E4orf6 proteins induce degradation of the
MRN complex, blocking NBS1 phosphorylation and preventing
concatemerization of viral genomes [15,39]. In contrast, differen-
tiating HPV positive cells exhibited high levels of NBS1, MRE11
and RAD50, which were maintained throughout differentiation.
In addition, we observed that NBS1 phosphorylation occurs
concomitantly with viral genome amplification, implicating NBS1
as a potential regulator of replication. The Rb associated
transcription factors E2F1 and E2F2 have been shown to interact
with MRE11 and NBS1 at both viral and cellular origins of
replication [55]. Upon differentiation, E7 induces increased
expression of E2F2, as well as its re-localization to nuclear foci,
which is necessary for viral genome amplification [56]. Recent
studies indicate that E2F2 binds to the region around the HPV-31
replication origin and increased binding was observed upon
differentiation [57]. It is possible that E2F2 directs MRN
components to HPV origins to ensure integrity of replication
forks and promote replication in differentiating cells.
Caspase activation has been shown to be an important and
novel means by which HPV proteins regulate amplification [7].
Low level caspase activation by E6 and E7 upon differentiation
induces cleavage of the E1 protein, which is required for efficient
viral genome amplification. Cleavage of E1 results in enhanced
binding of E1 to the origin and the ability to replicate in an E2-
independent manner (Moody, Archambault et al. unpublished
data). In the present study, we have found that CHK2 kinase
activity is necessary for caspase activation, as well as viral genome
amplification in differentiating cells. These results provide a
possible link between caspase cleavage and the activation of
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we have found that E6 can also activate CHK2 (Moody and
Laimins, unpublished data), although it is unclear whether E6
utilizes the DNA damage response to induce caspase activation in
differentiating cells. Several recent studies have demonstrated a
role for CHK2 in DNA damage-induced apoptosis [16,43,44,45].
In response to DNA damage, CHK2 phosphorylates E2F1,
resulting in its stabilization, transcriptional activation, and
induction of p53-dependent or -independent apoptosis [16,43].
E2F1 is expressed at high levels in differentiating HPV positive
cells [56], and it is possible that CHK2 mediates caspase activation
through E2F1. Interestingly, our studies indicate that HPV
induces caspase activation only in differentiating cells, while
activation of CHK2 is observed in both undifferentiated and
differentiated cells. This suggests that while CHK2 activation is
necessary for caspase activation, it alone is not sufficient and may
require differentiation-specific factors as well as other members of
the ATM pathway for this function. Several viruses have been
shown to utilize DNA damage response for productive replication,
and it is possible that these viruses also utilize low-level caspase
activation as part of their life cycle.
Our studies indicate that in stable cell lines E7 activates CHK2,
and that it forms a complex with the phosphorylated form of
ATM. Deletion of the LXCXE Rb binding domain in E7
abrogated ATM binding, however binding could occur directly or
indirectly through another protein. Preliminary results using Rb-
deficient Saos-2 cells indicate that E7 binding to ATM does not
require Rb (Moody and Laimins, unpublished data). Previous
studies have shown that deletion of the LXCXE binding domain
in E7 blocks HPV genome amplification [47], and in our studies
this motif is important for ATM binding. This is consistent with
the idea that E7’s interaction with ATM may be necessary for
productive replication.
In addition to E7, the HPV replication protein E1 may also
contribute to the ATM response. Upon differentiation, the
expression of E1 increases, contributing to enhanced viral
replication [58]. Kadaja et al demonstrated that heterologous
high-level expression of E1 initiates replication from integrated
HPV origins multiple times in a single S-phase [59]. This suggests
that E1 may disrupt normal licensing control in differentiating
cells, allowing for re-replication of HPV DNA and activation of an
ATM response. It is possible that multiple HPV proteins act
cooperatively to activate the full ATM response.
In summary, our studies demonstrate that HPV proteins activate
the ATM DNA damage response and that this is necessary for
amplification of viral genomes upon differentiation. The formation
of HPV replication foci in differentiating cells is dependent upon
ATM activity and suggests that DNA repair proteins may
participate directly in viral replication. Importantly, we have
established a link between caspase activation and the DNA damage
response. Caspase 3/7 consensus cleavage motifs are found at
conserved locations in E1 proteins of almost all papillomavirus
types, and we suspect caspase activation may be necessary for their
productive replication. We believe that activation of the ATM
pathway willproveto be a commonmechanismutilized byHPVs to
promote viral replication in differentiating cells. These observations
suggest that the ATM pathway may be an effective therapeutic
target to block the spread of HPV infections.
Materials and Methods
Cell culture
Human foreskin keratinocytes (HFKs) were derived from
neonatal human foreskin epithelia and maintained in E medium
containing mouse epidermal growth factor (EGF) and mitomycin-
treated J2 fibroblasts as previously described [60]. Human
osteosarcomacells (U2OS) were maintained in Dulbecco’s modified
Eagle’smedium(DMEM)containing10%bovineserum.CIN612is
a clonal cell line that stably maintains HPV-31 episomes. CIN612
cells were maintained in E medium with EGF and J2 fibroblast
feeders. Before harvesting DNA or protein, fibroblast feeders were
removed by treatment with phosphate-buffered saline (PBS)
containing 0.1% of .5 M EDTA for two minutes, followed by two
washes in PBS. Creation of HFK cell lines containing retroviral
constructs has been previously described [47].
Plasmids and chemicals
The pBR322min-HPV31 plasmid has been described [61]. The
HA-tagged E7 proteins were previously described [47] and are as
follows: HA-E7 DLHCYE contains an in-frame deletion of the Rb
binding domain and HA-E7 L67R contains a point mutation in the
HDAC binding site, converting a leucine to an arginine. KU-55933
and the CHK2 inhibitor II were obtained from Calbiochem.
Stable transfection of HFKs
Transfection of HFKs and selection for cells stably maintaining
HPV-31 genomes were performed as described previously [62].
Briefly, HPV-31 genomes were released from the pBR322 plasmid
by digestion with HindIII. Viral genomes were then unimolecu-
larly ligated with T4 DNA ligase (New England Biolabs) and
precipitated with isopropyl alcohol. HFKs were co-transfected
with 1 ug of religated genomes and 1 ug pSV2-Neo using
FuGene6 according to the manufacturer’s protocol (Roche).
Selection was carried out for eight days in the presence of G418
(Sigma). After selection was complete, pooled populations were
expanded for further analysis.
Calcium induced differentiation
Differentiation in high calcium was performed as described
previously [7]. Briefly, upon reaching 90% confluency, HPV-
positive cells and normal HFKs were cultured in keratinocyte
basal medium (KBM) with supplements (Invitrogen) for 24 hours.
Cells were then switched to KBM (without supplements)
containing 1.5 mM calcium chloride, and where indicated were
cultured with either DMSO, 5 or 10 uM KU-55933, or 5 uM of
the CHK2 inhibitor. At 48 and 96 hours, DNA was harvested
from one half of the cells, and protein was harvested from the
other half. Viral genome amplification was then measured by
Southern blot analysis to examine the episomal (supercoiled) form
of DNA to ensure that the productive phase of the viral life cycle
was activated. Western blot analysis was performed to analyze the
expression of differentiation-specific proteins.
Western blot and Southern blot analyses
Whole cell extracts were harvested in RIPA lysis buffer and
quantified using the Bio-Rad protein assay. Western blot analysis
was performed as described [47]. Equal amounts of protein were
electrophoresed on SDS-polyacrylamide gels and subsequently
transferred to polyvinylidene difluoride membrane (Immobilon-P;
Millipore). Primary antibodies were as follows: phospho-ATM
Ser1981 was purchased from R&D Systems. Phospho-CHK2
Thr68, CHK2, BRCA1, K10 and Involucrin were purchased from
Santa Cruz. ATM was purchased from Calbiochem. Phospho-
CHK1 Ser317, CHK1, phospho-CHK2 Thr68, phospho-BRCA1
Ser1524, Cleaved Caspase-7, and Caspase-7 were purchased from
Cell Signaling. Phospho-NBS1 Ser343, MRE11 and RAD50 were
purchased from Genetex. NBS1 was purchased from Novus
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linked anti-rabbit (Cell Signaling Technologies) and horseradish
peroxidase-linked anti-mouse (Santa Cruz). DNA isolation and
Southern blot analysis were performed as described [63].
HA-E7 protein expression and immunoprecipitation
U20S cells were transfected at 30% confluency with one
microgram of wild-type or mutant HA-tagged HPV-31 E7
proteins using FuGene6, according to the manufacturer’s
instructions (Roche). After 48 hours, lysates were harvested as
previously described [47]. Immunoprecipitations were performed
using one milligram of protein lysate. The samples were pre-
cleared for 1 hour with 40 ml of protein G agarose (Roche) at 4uC,
then incubated overnight with either a mouse anti-HA antibody
(Santa Cruz) or rabbit anti-ATM antibody (Calbiochem). Protein
complexes were then precipitated using 50 ml of protein G agarose
for 4 hours at 4uC. Immunoprecipitated complexes were then
washed three times with lysis buffer, and subsequently analyzed by
Western blot analysis using either mouse anti-HA, mouse anti-
pATM Ser1981 (Rockland), or rabbit anti-ATM antibodies.
Immunofluorescence and immunohistochemistry
HPV positive cells and normal HFKs were grown on coverslips
and induced to differentiate in high calcium in the presence of
DMSO or 10 uM KU-55933. At time 0 (undifferentiated) and
48 hr post-calcium induced differentiation, the cells were washed
three times in cold phosphate buffered saline (PBS), fixed in 4%
paraformaldehyde in PBS for 15 minutes, then permeabilized in
1%Triton X-100-PBS for 10 minutes. Cells were blocked with PBS
containing 10% bovine serum albumin (BSA) for one hour at room
temperature. Primary antibodies were diluted in PBS containing
10% BSA and incubated on coverslips overnight at 4uC. The
samples were then washed in PBS and stained with fluoroscein
isothiocyanate (FITC)-conjugated anti-rabbit antibody (1:50 dilu-
tion) (Zymed) or AlexaFluor 568 anti-mouse antibody (Invitrogen)
(1:400 dilution) for one hour at room temperature. Primary
antibody dilutions for mouse anti-phospho-ATM Ser1981 (Rock-
land), anti phospho-H2AX Ser139 (c-H2AX) (Upstate) were 1:400
and 1:500, respectively. Rabbit anti-phospho-CHK2 Thr68 (Cell
Signaling) and anti-phospho-H2AX Ser139 (c-H2AX) (Cell
Signaling) were diluted 1:50. Mouse anti-MRE11 and mouse anti-
Rad50 were diluted 1:200. Mouse anti-keratin 10 (K10) (Santa
Cruz) was diluted 1:100. Sections from normal keratinocyte raft
cultures or HPV-31 transfected keratinocyte raft cultures were
examined by immunofluorescence as described previously [63].
Cross sections of rafts were stained using a 1:50 dilution of anti-
phospho-CHK2 Thr68 (Cell Signaling), 1:200 of anti-pATM
Ser1981, or MRE11, 1:500 of c-H2AX Ser139 (Millipore), and
1:100 of anti-K10 (Santa Cruz). Cellular DNA was counterstained
withDAPI,andthe coverslipsorslidesweremountedinVectashield
(Vector Laboratories). Confocal images were acquired by a UV
LSM 510 confocal laser-scanning microscope (Zeiss). To quantify
number of cells containing DNA repair foci, at least 100 cells were
countedforthree independent experiments.Theaverage numberof
cells containing foci is indicated, along with the standard deviation.
Fluorescent in situ hybridization (FISH)
HPV-31 genomic DNA probes for FISH were prepared by nick
translation of plasmid genomic DNAs using the BioNick labeling
system according to the manufacturer’s instructions (Invitrogen).
Viral DNA was detected by tyramide fluorescent in situ
hybridization as previously described [64]. Briefly, 1610
6
undifferentiated HFK-31 cells, or HFK-31 cells differentiated in
high calcium for 48 hr were spread on Superfrost Plus slides
(Fisher) and allowed to air-dry. Cells were fixed with 4%
paraformaldehyde at room temperature followed by permeabiliza-
tion in 16PBS, 0.5% Triton X-100 for 10 min. The slides were
treated with 100 ug/ml RNase A in 26SSC for 1 hour at 37uC.
Subsequently, the slides were washed three times with 26 SSC,
then dehydrated for 2 min each in 70% EtOH, 85% EtOH and
100% EtOH at room temperature. Slides were then denatured in
70% formamide-26 SSC at 74uC for 2 minutes, followed by
dehydration for 2 min each in 70% EtOH (220uC), 85% EtOH
and 100% EtOH at room temperature. The probe was denatured
at 74uC for 10 minutes, and then 10 ul of probe was hybridized
overnight to the denatured slide at 37uC. After overnight
incubation, the slides were washed multiple times, and tyramide-
enhanced fluorescence was carried out according to the manu-
facturer’s instructions (Perkinelmer). The cellular DNA was
counterstained with DAPI, and the slides were mounted in
Vectashield. Images were collected using a UV LSM 510 confocal
laser-scanning microscope (Zeiss).
Supporting Information
Figure S1 MRN components are localized to nuclear foci in
HPV positive cells. HFK-31 cells, as well as normal HFKs were
harvested, fixed and permeabilized at either time 0 (undifferen-
tiated cells) or after 48 hr of calcium-induced differentiation.
Samples were stained with antibodies to either MRE11 or RAD50
and analyzed by confocal fluorescence microscopy. Cellular DNA
was counterstained with DAPI and is shown as merged with the
indicated antibodies.
Found at: doi:10.1371/journal.ppat.1000605.s001 (5.56 MB PDF)
Figure S2 DNA repair proteins exhibit a nuclear staining
pattern in raft cultures of HPV positive cells. Immunohistochem-
istry was performed on cross sections of organotypic raft cultures
generated from HFK-31 cells, as well as normal HFKs using
antibodies to (A) pATM Ser1981, (B) c-H2AX, (C) MRE11, or (D)
K10. Cellular DNA was counterstained with DAPI. Images were
captured using confocal fluorescence microscopy. pATM is found
in the basal and suprabasal cells in HFK-31 cells but only
background staining is observed in HFKs. MRE11 is distributed
throughout all epithelial layers for rafts generated from HFK-31
cells, as well as normal HFKs. c-H2AX is found at high levels in
all layers of HFK-31 rafts, and at reduced levels in normal HFK
rafts.
Found at: doi:10.1371/journal.ppat.1000605.s002 (2.77 MB PDF)
Figure S3 Southern analysis of HPV-31 cells treated with
inhibitors of ATM and CHK2. DNA was harvested from
undifferentiated CIN612 cells, as well as from cells induced to
differentiate for 48 and 96 hr in high calcium in the presence of
DMSO, 10 uM KU-55933 or 5 uM of the CHK2 inhibitor
(CHK2i). Total DNA was digested with either Xho1, which does
not cut the HPV genome (uncut), or with HindIII, which linearizes
the genome (cut). Southern blot analysis was performed to analyze
viral genome amplification. The four forms of HVP-31 DNA
found in this analysis are labeled. Standards of HPV genome
copies per cell are indicated to the left of the gel. Ca=calcium.
Found at: doi:10.1371/journal.ppat.1000605.s003 (0.80 MB PDF)
Figure S4 Analysis of the efficacy and specificity of the CHK2
inhibitor. Lysates were harvested from undifferentiated CIN612
cells, as well as after differentiation in high calcium for 48 and
96 hr in the presence of DMSO or 5 uM CHK2i. Western blot
analysis was performed using an antibody to the CHK2 substrate
pCdc25c Ser216, or to pCHK2 Thr68 or total CHK2. GAPDH
served as a loading control. Ca=calcium.
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